Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the african american-diabetes heart study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1916-1922

  Register, Thomas C ^a   Divers, Jasmin ^b   Bowden, Donald W ^b   Carr, J Jeffrey ^c   Lenchik, Leon ^c   Wagenknecht, Lynne E ^b   Hightower, R Caresse ^c   Xu, Jianzhao ^b   Smith, S Carrie ^b   Hruska, Keith A ^d   Langefeld, Carl D ^b   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Department of Public Health Sciences ^*  (United States)

^c Center for Radiology   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIUM; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; THIAZIDE DIURETIC AGENT;

ADIPOSE TISSUE; ADULT; AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; ILIAC ARTERY; INTRAABDOMINAL FAT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THORACIC SPINE;

ADIPONECTIN; ADIPOSITY; AFRICAN AMERICANS; AGED; BODY MASS INDEX; BONE DENSITY; BONE RESORPTION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NORTH CAROLINA; OBESITY; PLAQUE, ATHEROSCLEROTIC; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; VASCULAR CALCIFICATION;

EID: 84877706118     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4126     Document Type: Article

References (28)

1. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38(2):202-206.
2. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930-1935.
3. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79-83.
4. Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med (Berl). 2002; 80(11):696-702.
5. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947-953.
6. Lenchik L, Register TC, Hsu FC, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003; 33(4):646-651.
7. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res. 2004; 19(4):546-551.
8. Jurimae J, Rembel K, Jurimae T, Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res. 2005;37(5):297-302.
9. Richards JB, Leslie WD, Joseph L, et al. Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res. 2007;22(2):228-234.
10. Li FY, Cheng KK, Lam KS, Vanhoutte PM, Xu A. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf). 2011;203(1):167-180.
11. Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res. 2009; 24(8):1461-1468.
12. Carr JJ, Register TC, Hsu FC, et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone. 2008;42(1):43-52.
13. Divers J, Register TC, Langefeld CD, et al. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res. 2011;26(7): 1554-1560.
14. Bowden DW, Cox AJ, Freedman BI, et al. Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud. 2010;7(3):188-201.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
16. Divers J, Wagenknecht LE, Bowden DW, et al. Regional adipose tissue associations with calcified atherosclerotic plaque: African American Diabetes Heart Study. Obesity (Silver Spring). 2010; 18(10):2004-2009.
17. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Series B. 1964;26:211-246.
18. Anuurad E, Chiem A, Pearson TA, Berglund L. Metabolic syndrome components in African-Americans and European-American patients and its relation to coronary artery disease. Am J Cardiol. 2007;100(5):830-834.
19. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 2002;277(33):29359- 29362.
20. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation. 2000;102(11):1296-1301.
21. Shinoda Y, Yamaguchi M, Ogata N, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem. 2006;99(1):196-208.
22. Yokota T, Meka CS, Medina KL, et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002;109(10):1303-1310.
23. Maeda N, Takahashi M, Funahashi T, et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adiposederived protein. Diabetes. 2001;50(9):2094-2099.
24. Warman ML, Abbott M, Apte SS, γ. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet. 1993; 5(1):79-82.
25. Wallis GA, Rash B, Sykes B, γ. Mutations within the gene encoding the α1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia. J Med Genet. 1996;33(6):450-457.
26. Pitts CJ, Kearns AE. Update on medications with adverse skeletal effects. Mayo Clin Proc. 2011;86(4):338-343.
27. Riera-Guardia N, Rothenbacher D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab. 2008;10(5):367-375.
28. Williams GA, Wang Y, Callon KE, et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology. 2009;150(8):3603-3610.